Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great post
I think when we had the jump to $2.50, everyone got excited over the Flaskworks acquisition and we had data lock. Naturally we expected this to be followed by TLD. As time goes on, there is very little movement in terms of trading volume and the MMs are keeping a lid on the SP.
Us longs are holding on because we believe in the science and expect the data to show that DCVax shows a significant improvement compared to SOC in this awful disease. At the end of the day, the SP is irrelevant to those of us who do not trade every day for a few cents per share.
The only thing that really matters is that this treatment is approved and available for patients who need it. The rise in SP +/- BO/merger will follow. Direct will be developed imo and this will be a game changer in the treatment of cancer.
There is no way this stock will get to $2.50 before TLD. No way. After TLD, it will go beyond $5 pending RA approval, then afterwards who knows? But $20+ is not out of the question imho
Talk of SEC subpoena and German tax issues is all background noise. Lots of FUDster presence as we near TLD
What we need is a more effective treatment for this awful disease. That is all that really matters. If it takes a bit longer to ensure that all elements of the process are nailed down before a BLA application then that is fine by me.
We have mostly small volumes traded each day. SP will oscillate around the $1.35-1.50 mark until we see TLD. I can't see this spiking until then I'm afraid.
What utter BS
NWBO will be required to apply through MHRA for Market Authorisation for DCVax-L. Advent will have to apply to MHRA for the facility to be licensed in order to manufacture DCVax-L
Please do take A LOT of time over this - several days if you can. Give it all you got. I'm sure LP's lawyers will enjoy reading it
Clearly an increase in rodent activity on the Board today. I suspect we will see TLD in April. All the stars are aligning
I actually laughed out loud when I read this. Very funny
Eloquently put. Totally agree with your comments
Wow! Thanks for this. Very helpful!!
Agreed. The divergence of the OS curves over time is going to be a major factor in the outcome data imo. The stars are definitely aligning
My deepest condolences to you and your family.
Positive news alright! Drop in SP means more cheap shares
Heartbreaking story. I too cannot imagine why fellow human beings work to bury groundbreaking cancer treatments. It is beyond reprehensible
You can't analyze data that doesn't yet exist. Go away and do some reading
Why are you so worried about us all? Is it some altruistic gene that drives you to protect our money?
Well said
FDA vs EMA. Some interesting discussion points in this short article
FDA vs EMA
I think your summary is spot on Maverick
I do learn a huge amount from this MB and I always make sure I follow iwasadiver who speaks so much sense. thank you
well said Bright Boy!
good spot BSB, just saw this myself
Great post. I too am a strong believer in the science behind this treatment. Although we would all like to have some information, I'm being patient. After an inordinately long phase III trial, why rush the last bit and risk screwing up the whole thing at the final hurdle.
Wow! as soon as the SP drops, the negative posters come out in force. I've just bought some more. The science is sound and the results will bear this out.
well said
Great post!
Interesting news here
https://stemcell.ucla.edu/news/ucla-receives-73-million-grant-build-state-art-facility-developing-gene-cell-therapies
Liau, a neuro-oncologist, said the new facility will enable researchers to create personalized vaccines and cell therapies for a much larger number of patients.
“In the current facility, we are only able to enroll one patient at a time in our cell therapy trials, so many eligible patients have had to be turned away,” Liau said. “With greater capacity to manufacture gene and cell therapy products that meet FDA good manufacturing practice standards, this new UCLA facility will really allow us to further innovate and accelerate our translational research toward a cure for brain cancer.”
They refer to GBM as an ailment. Dictionary definition of ailment is "an illness, typically a minor one"